Sen. Ron Wyden (D-OR) (Francis Chung/E&E News/POLITICO via AP Images)
December 5, 2023 02:33 PM EST
Pharma
FDA+

The pol­i­tics be­hind drug short­ages: Sen­a­tors talk is­sues with gener­ics mar­ket, CMS pay­ments

Lia DeGroot

The gener­ic drug mar­ket took cen­ter stage Tues­day at a Sen­ate Fi­nance Com­mit­tee hear­ing on drug short­ages as law­mak­ers on Capi­tol Hill work to rem­e­dy …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Up­dat­ed: Ver­tex’s non-opi­oid pill dis­ap­points in mid-stage chron­ic pain study

The End­points 2024 win­ners and losers list: Who was up and who was down in bio­phar­ma

Roche’s Parkin­son’s drug flunks sec­ond mid-stage tri­al

David Ep­stein gets $140M for Ot­ti­mo's bi­func­tion­al take on hot PD-1xVEGF field

Sang­amo strikes an­oth­er brain-tar­get­ing AAV part­ner­ship, this time with Astel­las

Bris­tol My­ers pays $100M up­front to col­lab­o­rate with Leqem­bi orig­i­na­tor in Alzheimer's

A service from the Financial Times